Preserved epitope-specific T cell activation by recombinant bet v 1-MBP fusion proteins

Clinical and Experimental Allergy

Volumn 28, Issue 4, 1998, Pages 423-433

  Van Neerven, R J J ^a   Sparholt, S H ^a   Schou, C ^a   Larsen, J N ^a  

^a ALK ABELLÓ   (Denmark)

Author keywords

Bet v 1; Fusion protein; Recombinant allergens; Specific immunotherapy; T cell clone; T cell epitope; TH1 biasing factor

Indexed keywords

ALLERGEN; FUSION PROTEIN BET V 1; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; RECOMBINANT FUSION PROTEIN BET V 1; UNCLASSIFIED DRUG;

ALLERGENICITY; ARTICLE; EPITOPE MAPPING; GENE AMPLIFICATION; GENE SEQUENCE; IMMUNOTHERAPY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE ACTIVATION;

ALLERGENS; AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; CARRIER PROTEINS; CELL LINE; CLONE CELLS; CLONING, MOLECULAR; CYTOKINES; EPITOPES; ESCHERICHIA COLI PROTEINS; GENES, BACTERIAL; GENES, PLANT; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MONOSACCHARIDE TRANSPORT PROTEINS; PLANT PROTEINS; PLASMIDS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0031950275     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00259.x     Document Type: Article

References (49)

1. Ipsen H, Løwenstein H. Isolation and immunochemical characterisation of the major allergen of birch pollen (Betula verrucosa). J Allergy Clin Immunol 1983; 72:150.
2. Jarolim E, Rumpold H, Endler AT et al. IgE and IgG antibodies of patients with allergy to birch as tools to define the allergen profile of Betula verrucosa. Allergy 1989; 44:385-95.
3. Ipsen H, Wihl JA, Petersen BN, Løwenstein H. Specificity mapping of patients IgE response towards the tree pollen major allergens, Aln g 1, Bet v 1 and Cor a 1. Clin exp Allergy 1992; 22:391-9.
4. Ipsen H, Hansen OC. The NH. 2-terminal amino acid sequence of the immunochemically partial identical major allergens of alder (alnus glutinosa) Aln g 1. birch (Betula verrucosa) Bet v 1, hornbeam (Carpinus betulus) Car b 1 and oak (Quercus alba) Que a 1 pollens. Mol Immunol 1991; 28:1279-88.
5. Breiteneder H, Pettenburger K, Bito A et al. The gene coding for the major birch allergen, Bet v I, is highly homologous to a pea disease resistance response gene. EMBO J 1989; 8:1935.
6. Swoboda I, Jilek A, Ferreira F et al. Isoforms of Bet v 1, the Major Birch Pollen Allergen. Analyzed by Liquid Chromatography, Mass Spectrometry, and cDNA Cloning. J Biol Chem 1995; 270:2607-13.
7. Larsen JN, Casals AB, From NB, Stroman P, Ipsen H. Characterization of recombinant Bet v 1, the major pollen allergen of Betula verrucosa (white birch), produced by fed-batch fermentation. Int Arch Allergy Immunol 1993; 102:249-58.
8. Larsen JN, Stroman P, Ipsen H. PCR based cloning and sequencing of isogenes encoding the tree pollen major allergen Car b 1 from Carpinus betulus, hornbeam. Mol Immunol 1992; 29:703-11.
9. Breiteneder H, Ferreira F, Reikerstorfer A et al. Complementary cDNA cloning and expression in Escherichia coli of Aln g 1, the major allergen in pollen of alder (Alnus glutinosa). J Allergy Clin Immunol 1992; 90:909-17.
10. Breiteneder H, Ferreira F, Hoffmann-Sommergruber K et al. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE binding properties. Eur J Biochem 1993; 552:1-8.
11. Gajhede M, Osmark P, Poulsen FM et al. X-Ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nature Struct Biol 1996; 3:1040-5.
12. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM. Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 1991; 12:392-5.
13. Wierenga EA, Snoek M. de Groot CJ et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144:4651-6.
14. Parronchi P. Macchia D, Piccinni M et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88:4538-42.
15. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97:389-94.
16. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
17. Del Prete GF, De Carli M, D'Elios MM et al. Allergen exposure induces the activation of allergen-specific TH2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23:1445-9.
18. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J Clin Invest 1993; 92:644-51.
19. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
20. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee Venom Immunotherapy Results in Decrease of IL-4 and IL-5 and Increase of IFN-τ Secretion in Specific Allergen Stimulated T Cell Cultures. J Immunol 1995; 154:4187-94.
21. Durham SR, Ying S, Varney VA et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-g. J Allergy Clin Immunol 1996; 97:1356-65.
22. O'Callagan D, Martineau P, Fayolle C et al. Immune responses to hybrid maltose-binding proteins. Vaccine 1993; 11:140-2.
23. Leclerc C, Lo-Man R, Charbit A, Martineau P, Clement JM, Hofnung M. Immunogenicity of viral B-, T. -cell epitopes expressed in recombinant bacterial proteins. Int Rev Immunol 1994; 11:123-32.
24. Zhang T, Cieslak PR, Stanley SLj. Protection of gerbils from amebic liver abcess by immunization with a recombinant Entamoeba histolytica antigen. Infect Immun 1994; 62:1166-70.
25. Sparholt SH, Larsen JN, Ipsen H, Schou C, van Neerven RJJ. Crossreactivity and T. cell epitope-specificity of Bet v 1-specific T cells suggest the involvement of multiple isoallergens in the sensitization to birch pollen. Clin Exp Allergy 1997; 27:932-41.
26. Axelsen NH, Bock E. Electroimmunoassay (Rocket Immunoelectroforesis). Scand J Immunol 1983; 17(Suppl. 10): 103-6.
27. Woodhead JS, Weeks I. Magic Lite design and development. J Biolumin Chemilumin 1989; 4:611-4.
28. Yssel H, Johnson KE, Schneider PV et al. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J Immunol 1992; 148:738-45.
29. van Neerven RJJ, 't Hof W, Ringrose JH et al. T cell epitopes of house dust mite major allergen Der p II. J Immunol 1993; 151:2326-35.
30. O'Hehir RE, Verhoef A, Panagiotopoulou E, Keswani S, Thomas WR, Lamb JR. Analysis of human T. cell responses to the group II allergen of Dermatophagoides Spp. (house dust mite): Localisation of major antigenic sites. J Allergy Clin Immunol 1993; 92:105-13.
31. Higgins JA, Thorpe CJ, Hayball JD, O'Hehir RE, Lamb JR. Overlapping T. cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol 1994; 93:891-9.
32. Carballido JM, Carballido-Perrig N, Kagi MK et al. T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol 1993; 150:3582-91.
33. Ebner C, Schenk S, Szepfalusi Z et al. Multiple T cell specificities for Bet v I, the major birch pollen allergen, within single individuals. Studies using specific T cell clones and overlapping peptides. Eur J Immunol 1993; 23:1523-7.
34. Ebner C, Szepfalusi Z, Ferreira F et al. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993; 150:1047-54.
35. van Neerven RJJ, de Pol MM, van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg ML. Charaterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994; 152:4203-10.
36. Spiegelberg HL, Beck L, Stevenson DD, Ishioka GY. Recognition of T. cell epitopes and lymphokine secretion byrye grass allergen Lolium perenne I-specific human T cell clones. J Immunol 1994; 152:4706-11.
37. van Neerven RJJ, Ebner C, Yssel H, Kapsenberg ML, Lamb JR. T Lymphocyte responses to allergens: Epitope-specificity and clinical relevance. Immunol Today 1996; 17:526-32.
38. Ebner C, Ferreira F, Hofmann K et al. T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I. Mol Immunol 1993; 30:1323-9.
39. Schenk S, Hoffmann-Sommergruber K, Breiteneder H et al. Four recombinant isoforms of Cor a 1, the major allergen og hazel pollen, show different reactivity with allergen-specific T lymphocyte clones. Eur J Biochem 1994; 224:717.
40. Ferreira F, Hirtenlehner K, Jilek A et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1 : Potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996; 183:599-609.
41. Scheiner O, Kraft D. Basic and practical aspects of recombinant allergens. Allergy 1995; 50:384-91.
42. Menz G, Dolecek C, Schoenheit-Kenn U et al. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin exp Allergy 1996; 26:50-60.
43. Østerballe O, Ipsen H, Weeke B, Løwenstein H. Specific IgE. response toward allergenic molecules during perennial hyposensitization: A three year prospective double blind study. J Allergy Clin Immunol 1983; 71:40-6.
44. Sun JB, Holmgren J, Czerkinsky C. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 1994; 91:10795-9.
45. Hsu CH, Chua KY, Tao MH et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 1996; 2:540-4.
46. Raz E, Tighe H, Sato Y et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996; 93:5141-5.
47. Vrtala S, Grote M, Ferreira F et al. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine. Int Arch Allergy Immunol 1995; 107:290-4.
48. Vrtala S, Hirtenlehner K, Vangelista L et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments-Candidates for a novel form of specific immunotherapy. J Clin Invest 1997; 99:1673-81.
49. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE induction. J Immunol 1997; 158:4137-44.